Skip to main content
. 2023 May 22;23(10):4983. doi: 10.3390/s23104983

Table 1.

Clinical and spatio-temporal gait characteristics of the included subjects.

swPD HS p
Age [mean(SD)] 71.15 (5.12) 69.14 (4.80) 0.06
Gender [n (%)] F 15 (29.41) 27 (54) 0.01
M 36 (70.58) 23 (46)
Disease duration [mean(SD)] 8.04 (4.70)
HY [n (%)] 1 10 (19.60)
2 17 (33.33)
3 24 (47.05)
UPDRS III [mean(SD)] 41.41 (18.22)
UPDRS III < 32 [n (%)] 16 (31.27)
UPDRS III ≥ 32 [n (%)] 22 (43.13)
UPDRS III ≥ 58 [n (%)] 13 (25.49)
History of falls (n° of falls in the previous 6 months) [mean (SD)] 1.35 (3.28)
Gait speed (m/s) [mean (SD)] 1.08 (0.25) 1.09 (0.25) 0.91
Stance phase (% gait cycle) [mean (SD)] 60.82 (2.27) 61.41 (3.42) 0.31
Swing phase (% gait cycle) [mean (SD)] 39.18 (2.27) 38.59 (3.42) 0.31
Single support (% gait cycle) [mean (SD)] 39.24 (2.92) 37.93 (5.29) 0.13
Double support (% gait cycle) 10.88 (2.33) 11.90 (4.92) 0.19
Cadence (steps/min) [mean (SD)] 103.37 (20.44) 101.35 (14.06) 0.60
Stride length (m) [mean (SD)] 0.94 (0.21) 1.22 (0.22) <0.00
Pelvic tilt (°) [mean (SD)] 3.33 (1.55) 3.01 (1.13) 0.25
Pelvic obliquity (°) [mean (SD)] 3.87 (2.16) 5.38 (2.70) 0.01
Pelvic rotation (°) [mean (SD)] 5.49 (3.29) 6.68 (3.90) 0.02
HR AP [mean (SD)] 1.66 (0.26) 2.32 (0.64) <0.00
HR ML [mean (SD)] 1.62 (0.25) 2.23 (0.59) <0.00
HR V [mean (SD)] 1.68 (0.28) 2.41 (0.76) <0.00
stride length CV % [mean (SD)] 39.26 (19.44) 26.69 (13.76) 0.00

swPD, subjects with Parkinson’s disease; HS, age and speed-matched healthy subjects; p, significance level at 95% confidence interval in Mann–Whitney procedure; HY, Hoehn and Yahr disease stage classification; UPDRS III, motor section of the Unified Parkinson’s Disease Rating Scale; HR, Harmonic Ratio; AP, antero-posterior direction of the acceleration signal; ML medio-lateral direction of the acceleration signal; V vertical direction of the acceleration signal; CV, coefficient of variation.